Exclusive: FDA plans new compounding pharmacy policy, agency head says

BOSTON (Reuters) – The head of the U.S. Food and Drug Administration said on Friday the agency is working on a new policy that would encourage more compounding pharmacies to register under a law enacted in the wake of a deadly 2012 meningitis outbreak linked to one such company.
Original Article

more recommended stories